Report Overview
-
Request a Free Sample to learn more about this report
The global size exclusion chromatography (SEC) HPLC column market size was USD 438.5 million in 2021. As per our research, the market is expected to reach USD 796.8 million in 2028, exhibiting a CAGR of 8.8% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with size exclusion chromatography (SEC) HPLC column market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
By separating and analyzing molecules according to their size or molecular weight, size exclusion chromatography (SEC) is a type of liquid chromatography. This method uses a stationary phase of porous beads with a specified pore size distribution, and SEC HPLC columns are columns specifically made for this method. In many different applications, including protein analysis, polymer analysis, and quality monitoring of biological products, size exclusion chromatography (SEC) HPLC columns are frequently used.
The market for size exclusion chromatography (SEC) HPLC columns is expanding as a result of the rising demand in the biopharmaceutical and life sciences sectors for effective and dependable separation methods. The study of biomolecules including proteins, peptides, and nucleic acids is frequently carried out using SEC HPLC columns, which is why these columns are crucial for drug development and quality control. The SEC HPLC column sector is expanding as a result of technological developments such the creation of better resins and columns with higher resolution and sensitivity.
COVID-19 Impact: Disruption of the Supply Chain Resulted in Shortage of Raw Materials
Many unfavorable effects of the COVID-19 epidemic have been observed in the HPLC column industry. The disruption of the global supply chain caused by production facility closures and transit limitations, which resulted in a shortage of raw materials and delivery delays, was one of the biggest problems the market faced. Due to the large price increase brought on by this, some end users were no longer able to afford SEC HPLC columns. At several organizations, budget cuts as a result of the pandemic's economic uncertainties reduced their capacity to fund research and development, including the acquisition of these columns.
Latest Trends
"Using High-performance Columns with Enhanced Sensitivity for Less Frequent Replacements"
The growing use of high-performance columns with increased resolution and sensitivity is one of the most recent trends in the size exclusion chromatography (SEC) HPLC column industry. In order to deliver better resolution and quicker analysis times, manufacturers are investing in R&D to create SEC HPLC columns with cutting-edge materials, enhanced particle sizes, and improved pore size distributions. These columns are also intended to be stronger and more resilient, resulting in longer lifespans and less frequent replacement. In general, the newest advancements in the SEC HPLC Column market are concentrated on providing more efficient and reliable analysis of complex biomolecules with improved resolution, sensitivity, and automation.
Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into ID Below 4.6mm, ID 4.6-7.8mm and ID Above 7.8mm
- By Application Analysis
Based on application, the market can be divided into Pharmaceutical and Biotech Company, Academic & Research Institutions and Others
Driving Factors
"HPLC Industry is Being Driven by the Developing Biopharmaceutical Sector"
Due to the rising need for innovative medicines and personalized medicine, the biopharmaceutical business is expanding significantly. For the analysis and quality control of biomolecules used extensively in the biopharmaceutical sector, such as proteins, peptides, and nucleic acids, SEC HPLC columns are crucial. As a result, one of the key factors propelling the market for size exclusion chromatography (SEC) HPLC columns is the expansion of the biopharmaceutical sector.
"Increased Emphasis on R&D Due to Rising Demand for Personalized Medication"
The need for SEC HPLC columns is being fueled by the increased emphasis on research and development across a variety of sectors, including pharmaceuticals, biotechnology, and life sciences. Complex biomolecules are frequently utilized in research and development, making these columns crucial for the study and purification of these substances. A more sophisticated size exclusion chromatography (SEC) HPLC column is required in order to handle complex biomolecules with greater sensitivity and resolution, which is driven in part by the growing need for customized medicine and precision healthcare.
Restraining Factors
"High Cost Involved with the Columns Might Hinder the Expansion of the Industry"
The high cost involved with the development, production, and acquisition of these products is a significant restraint on the size exclusion chromatography (SEC) HPLC column market growth. Specialized materials and methods are needed, together with extensive R&D and quality control efforts, for the manufacture of the columns. The price of HPLC columns is also increased by the high cost of raw materials and manufacturing tools. Generally speaking, the high price of SEC columns is a significant market restraint as it might prevent adoption and expansion, especially in price-sensitive market groups.
Regional Insights
-
Request a Free Sample to learn more about this report
"Well Established Pharmaceutical and Biotechnology Sectors are Driving the Regional Market "
In terms of revenue and demand, North America is anticipated to rule the size exclusion chromatography (SEC) HPLC column market share throughout the projected timeline. This is explained by the presence of numerous important companies in the area, considerable R&D expenditures, and an increase in the demand for cutting-edge treatments and personalized medicine. Furthermore, the region's well-established pharmaceutical and biotechnology sectors are what are driving the demand for HPLC columns for R&D projects and quality assurance of biopharmaceuticals. Demand for SEC columns in the area is also anticipated to increase as a result of the growing emphasis on precision medicine and the creation of cutting-edge treatments such as cell and gene therapies.
Key Industry Players
"Key Players Focus on Alliances and Mergers to Grow their Market Positions"
Businesses in the size exclusion chromatography (SEC) HPLC column are forming alliances with other significant market participants to broaden their product offering and delivery system. These alliances can give businesses access to new markets and clients, enable them to offer a wider range of products, and give them a competitive edge. To grow their market position and share, several businesses are now partaking in mergers and acquisitions. Companies can acquire new technology, product lines, and customer bases through acquisitions, which can aid them in achieving their growth goals.
List of Market Players Profiled
- Agilent Technologies (U.S.)
- Waters Corporation (U.S.)
- Shimadzu (Japan)
- Tosoh Corporation (Japan)
- Thermo Fisher Scientific (U.S.)
- Danaher (U.S.)
- Bio-Rad (U.S.)
- Merck (Germany)
Report Coverage
This report covers the size exclusion chromatography (SEC) HPLC column market. The CAGR expected to be in during the forecast period, and also the USD value in 2021 and what it is expected to be in 2028. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In | US$ 438.5 Million in 2021 |
Market Size Value By | US$ 796.8 Million by 2028 |
Growth Rate | CAGR of 8.8% from 2021 to 2028 |
Forecast Period | 2022-2028 |
Base Year | 2021 |
Historical Data Available | Yes |
Segments Covered | Type and Application |
Regional Scope | Global |
Frequently Asked Questions
-
What value is the global size exclusion chromatography (SEC) HPLC column market expected to touch by 2028?
The global size exclusion chromatography (SEC) HPLC column market is expected to touch USD 796.8 million by 2028.
-
What CAGR is the size exclusion chromatography (SEC) HPLC column market expected to exhibit during 2022-2028?
The size exclusion chromatography (SEC) HPLC column market is expected to exhibit a CAGR of 8.8% over 2022-2028.
-
Which are the driving factors of the size exclusion chromatography (SEC) HPLC column market?
The HPLC industry is being driven by the developing biopharmaceutical sector and increased emphasis on R&D due to rising demand for personalized medication are the driving factors of the size exclusion chromatography (SEC) HPLC column market.
-
Which are the top companies operating in the size exclusion chromatography (SEC) HPLC column market?
Agilent Technologies, Waters Corporation, Shimadzu, Tosoh Corporation and Thermo Fisher Scientific are the top companies operating in the size exclusion chromatography (SEC) HPLC column market.